{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Gainesville",
      "address_1": "2481 Hilton Dr",
      "reason_for_recall": "Labeling: Label Mix-up: The affected units were labeled incorrectly describing the product as \"ointment\" instead of \"solution.\"",
      "address_2": "",
      "product_quantity": "22 units",
      "code_info": "Lot 06JN1265 Exp 3/14 and 06JN1266 Exp 4/14",
      "center_classification_date": "20121109",
      "distribution_pattern": "FL, PA, and VA.",
      "state": "GA",
      "product_description": "Tobramycin Ophthalmic Oint., 0.3%, 5ml bottle, (Generic for: Tobrex), Rx only, Sterile, Mfg By Akorn, Inc., Lake Forest, IL 60045, NDC 16590-224-05,",
      "report_date": "20121121",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Stat Rx USA",
      "recall_number": "D-050-2013",
      "initial_firm_notification": "E-Mail",
      "product_type": "Drugs",
      "event_id": "62940",
      "termination_date": "20130131",
      "more_code_info": "",
      "recall_initiation_date": "20120618",
      "postal_code": "30501-6213",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}